Mr. Elam joined the company in October 2012 and he is a Managing Director of Konus Advisory Group, a boutique healthcare firm. Mr. Elam has also been CEO of a surgical medical device company based in Europe since 2009 and prior to that he ran the Pulmonary Business Unit of Nektar Therapeutics which he sold to Novartis in 2008. Mr. Elam has spent his entire career starting, managing and advising emerging growth companies. Earlier in his career he was a corporate partner with Wilson Sonsini Goodrich & Rosati and he holds a J.D. from Harvard University and bachelor’s degree from Howard University. In addition to the AntriaBio board of directors, Mr. Elam sits on the board of Savara Pharmaceuticals in Austin, Texas and Aerogen, Limited in Galway, Ireland.

Recent Posts

Forward Looking Statements

This release, like many written and oral communications presented by AntriaBio, Inc., and our authorized officers, may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of the Company, are generally identified by use of words "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "seek," "strive," "try," or future or conditional verbs such as "could," "may," "should," "will," "would," or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, AntriaBio undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

This Blog is official and sanctioned by AntriaBio, Inc. | See Disclaimer and Terms of Use

Get AntriaBio, Inc. Blog Post Alerts